Preliminary Screening of South African Plants for Binding Affinity to the Serotonin Reuptake Transporter and Adenosine A1/A2A Receptors
Open Access
- 22 August 2023
- journal article
- research article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 91 (3) , 41
Abstract
In South African traditional medicine, Gomphocarpus fruticosus (L.) W.T. Aiton, Hypoxis hemerocallidea Fisch. & C.A. Mey., and Leonotis leonurus. (L.) R.Br. have been recorded among different ethnic groups to be a valuable herbal remedy for the management of depression-related conditions. The current study investigated the affinity of these three plants toward the serotonin reuptake transporter (SERT) and adenosine A1/A2 receptors. Six solvents (water, methanol, acetone, dichloromethane, petroleum ether, and hexane) were used to extract the selected plants. We established that eight extracts exerted potential affinity based on the applied in vitro binding experiment. The methanol and acetone extracts of Hypoxis hemerocallidea had 60% specific binding of [3H]citalopram, an indication that almost 40% of the plant extracts were bound to the SERT. For the adenosine receptor binding assays, methanol and hexane extracts of Leonotis leonurus were the most active, with rA1Ki values of 0.038 and 0.176 mg/mL, respectively. In addition, the dichloromethane extract of Gomphocarpus fruticosus had an rA1Ki value of 6.46 mg/mL. Extracts from the more polar solvents methanol and dichloromethane had higher binding affinity. Additionally, these plant extracts acted as antagonists at the adenosine A1 receptor. Overall, the current findings provide an indication of the potential antidepressant effects of some of the tested extracts based on their binding to the receptors evaluated. However, a combination of other in vitro assays is needed to establish possible mechanisms of action. In addition, computational analysis and profiling of plant extracts is crucial to identify the bioactive compounds with a higher affinity to the receptors. Ultimately, in vivo studies remain essential to allow for an in-depth elucidation of the mechanisms of action.Keywords
Funding Information
- DSI/NWU Preclinical Drug Development Platform (PCDDP), South African Medical Research Council (MRC) self-initiated funding and the National Research Foundation (UID 129 870)
This publication has 30 references indexed in Scilit:
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010PLOS Medicine, 2013
- Green tea and coffee consumption is inversely associated with depressive symptoms in a Japanese working populationPublic Health Nutrition, 2013
- Benzothiazinones: A Novel Class of Adenosine Receptor Antagonists Structurally Unrelated to Xanthine and Adenine DerivativesJournal of Medicinal Chemistry, 2012
- Coffee, Caffeine, and Risk of Depression Among WomenArchives of internal medicine (1960), 2011
- Adenosine A2A receptors and basal ganglia physiologyProgress in Neurobiology, 2007
- Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled ratsEuropean Journal of Neuroscience, 2003
- Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout miceBritish Journal of Pharmacology, 2001
- Ribose-Modified Adenosine Analogs as Potential Partial Agonists for the Adenosine ReceptorJournal of Medicinal Chemistry, 1995
- Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteinsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976